152 related articles for article (PubMed ID: 12871553)
1. Lineage-specific overexpression of the P2Y1 receptor induces platelet hyper-reactivity in transgenic mice.
Hechler B; Zhang Y; Eckly A; Cazenave JP; Gachet C; Ravid K
J Thromb Haemost; 2003 Jan; 1(1):155-63. PubMed ID: 12871553
[TBL] [Abstract][Full Text] [Related]
2. (N)-methanocarba-2MeSADP (MRS2365) is a subtype-specific agonist that induces rapid desensitization of the P2Y1 receptor of human platelets.
Bourdon DM; Mahanty SK; Jacobson KA; Boyer JL; Harden TK
J Thromb Haemost; 2006 Apr; 4(4):861-8. PubMed ID: 16634757
[TBL] [Abstract][Full Text] [Related]
3. The P2Y1 receptor plays an essential role in the platelet shape change induced by collagen when TxA2 formation is prevented.
Mangin P; Ohlmann P; Eckly A; Cazenave JP; Lanza F; Gachet C
J Thromb Haemost; 2004 Jun; 2(6):969-77. PubMed ID: 15140133
[TBL] [Abstract][Full Text] [Related]
4. Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice.
Fabre JE; Nguyen M; Latour A; Keifer JA; Audoly LP; Coffman TM; Koller BH
Nat Med; 1999 Oct; 5(10):1199-202. PubMed ID: 10502826
[TBL] [Abstract][Full Text] [Related]
5. Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro.
Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM
Platelets; 2003; 14(7-8):445-62. PubMed ID: 14713514
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of platelet function by administration of MRS2179, a P2Y1 receptor antagonist.
Baurand A; Raboisson P; Freund M; Léon C; Cazenave JP; Bourguignon JJ; Gachet C
Eur J Pharmacol; 2001 Feb; 412(3):213-21. PubMed ID: 11166284
[TBL] [Abstract][Full Text] [Related]
7. P2 receptors and platelet activation.
Kunapuli SP
ScientificWorldJournal; 2002 Feb; 2():424-33. PubMed ID: 12806027
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets.
Jin J; Daniel JL; Kunapuli SP
J Biol Chem; 1998 Jan; 273(4):2030-4. PubMed ID: 9442040
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of activation and functional role of protein kinase Ceta in human platelets.
Bynagari YS; Nagy B; Tuluc F; Bhavaraju K; Kim S; Vijayan KV; Kunapuli SP
J Biol Chem; 2009 May; 284(20):13413-13421. PubMed ID: 19286657
[TBL] [Abstract][Full Text] [Related]
10. Calmodulin interacts with the platelet ADP receptor P2Y1.
Arthur JF; Shen Y; Mu FT; Leon C; Gachet C; Berndt MC; Andrews RK
Biochem J; 2006 Sep; 398(3):339-43. PubMed ID: 16848759
[TBL] [Abstract][Full Text] [Related]
11. Loss of P2Y
Paul DS; Blatt TN; Schug WJ; Clark EG; Kawano T; Mackman N; Murcia S; Poe KO; Mwiza JMN; Harden TK; Bergmeier W; Nicholas RA
J Thromb Haemost; 2023 Jul; 21(7):1891-1902. PubMed ID: 36958516
[TBL] [Abstract][Full Text] [Related]
12. Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation.
Vigne P; Hechler B; Gachet C; Breittmayer JP; Frelin C
Biochem Biophys Res Commun; 1999 Mar; 256(1):94-7. PubMed ID: 10066429
[TBL] [Abstract][Full Text] [Related]
13. Role of P2Y1 purinoceptor in ADP-induced platelet activation.
Savi P; Beauverger P; Labouret C; Delfaud M; Salel V; Kaghad M; Herbert JM
FEBS Lett; 1998 Feb; 422(3):291-5. PubMed ID: 9498802
[TBL] [Abstract][Full Text] [Related]
14. Induction of novel agonist selectivity for the ADP-activated P2Y1 receptor versus the ADP-activated P2Y12 and P2Y13 receptors by conformational constraint of an ADP analog.
Chhatriwala M; Ravi RG; Patel RI; Boyer JL; Jacobson KA; Harden TK
J Pharmacol Exp Ther; 2004 Dec; 311(3):1038-43. PubMed ID: 15345752
[TBL] [Abstract][Full Text] [Related]
15. Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: role of P2Y₁ and P2Y₁₂ receptors.
Aslam M; Sedding D; Koshty A; Santoso S; Schulz R; Hamm C; Gündüz D
Thromb Res; 2013 Nov; 132(5):548-57. PubMed ID: 24071464
[TBL] [Abstract][Full Text] [Related]
16. The central role of the P(2T) receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity.
Storey RF; Sanderson HM; White AE; May JA; Cameron KE; Heptinstall S
Br J Haematol; 2000 Sep; 110(4):925-34. PubMed ID: 11054084
[TBL] [Abstract][Full Text] [Related]
17. The P2Y1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel.
Hechler B; Eckly A; Ohlmann P; Cazenave JP; Gachet C
Br J Haematol; 1998 Dec; 103(3):858-66. PubMed ID: 9858246
[TBL] [Abstract][Full Text] [Related]
18. The role of ADP receptors in platelet function.
Murugappa S; Kunapuli SP
Front Biosci; 2006 May; 11():1977-86. PubMed ID: 16368572
[TBL] [Abstract][Full Text] [Related]
19. Role of P2Y receptor subtypes in platelet-derived microparticle generation.
Kahner BN; Dorsam RT; Kunapuli SP
Front Biosci; 2008 Jan; 13():433-9. PubMed ID: 17981558
[TBL] [Abstract][Full Text] [Related]
20. Pennogenin tetraglycoside stimulates secretion-dependent activation of rat platelets: evidence for critical roles of adenosine diphosphate receptor signal pathways.
Cong Y; Liu X; Kang L; Yu Z; Zhao Z; Li J; Ma B; Cong Y
Thromb Res; 2012 May; 129(5):e209-16. PubMed ID: 22401797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]